ReviewChemical reviews2014
Nonredox nickel enzymes.
Review in Chemical reviews, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
70 citing papers in PubMed.
- Nickel Single-Atom Nanozyme for Multimodal Cancer Therapy.ACS applied materials & interfaces · 2026Article
- HalogenatedACS medicinal chemistry letters · 2025Article
- Article
- Appended Lewis Acids Enable Dioxygen Reactivity and Catalytic Oxidations with Ni(II).Journal of the American Chemical Society · 2024Article
- A database overview of metal-coordination distances in metalloproteins.Acta crystallographica. Section D, Structural biology · 2024Article
- Article
- Metal selectivity and translocation mechanism characterization in proteoliposomes of the transmembrane NiCoT transporter NixA fromChemical science · 2024Article
- POCOP-Ni(II) pincer compounds derived from phloroglucinol. Cytotoxic and antioxidant evaluation.Frontiers in chemistry · 2024Article
- Benzimidazole-acrylonitrile hybrid derivatives act as potent urease inhibitors with possible fungicidal activity.Future medicinal chemistry · 2024Article
- An overview: metal-based inhibitors of urease.Journal of enzyme inhibition and medicinal chemistry · 2023Review
- Article
- Synthesis of amantadine clubbedRSC advances · 2023Article
- Delivering a toxic metal to the active site of urease.Science advances · 2023Article
- Optimized Ebselen-Based Inhibitors of Bacterial Ureases with Nontypical Mode of Action.Journal of medicinal chemistry · 2023Article
- The elements of life: A biocentric tour of the periodic table.Advances in microbial physiology · 2023Article
- How Theoretical Evaluations Can Generate Guidelines for Designing/Engineering Metalloproteins with Desired Metal Affinity and Selectivity.Molecules (Basel, Switzerland) · 2022Review
- Inhibition of Urease by Hydroquinones: A Structural and Kinetic Study.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022Article
- Synthesis and Identification of NewMolecules (Basel, Switzerland) · 2022Article
- Exploring Novel Pyridine Carboxamide Derivatives as Urease Inhibitors: Synthesis, Molecular Docking, Kinetic Studies and ADME Profile.Pharmaceuticals (Basel, Switzerland) · 2022Article
- Metabolic Profiling by GC-MS,Molecules (Basel, Switzerland) · 2022Article
10 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.